Yue Hui Su
Direktor/Vorstandsmitglied bei MAKALOT INDUSTRIAL CO., LTD.
Profil
Yue Hui Su is currently serving as an Independent Director at Makalot Industrial Co., Ltd., In Win Development, Inc., CECI Engineering Consultants, Inc., Ennoconn Corp., Formosa Pharmaceuticals, Inc., and Soochow University as a Professor in the Accounting Department.
Previously, Dr. Su held positions as an Independent Director at TWi Pharmaceuticals, Inc., a Member of the Supervisory Board at Bank of Kaohsiung Co., Ltd., and a Professor in the Accounting Department at Soochow University.
Dr. Su completed their undergraduate, graduate, and doctorate degrees at National Taiwan University.
Aktive Positionen von Yue Hui Su
Unternehmen | Position | Beginn |
---|---|---|
MAKALOT INDUSTRIAL CO., LTD. | Direktor/Vorstandsmitglied | 21.02.2011 |
IN WIN DEVELOPMENT INC. | Direktor/Vorstandsmitglied | 01.07.2015 |
ENNOCONN CORPORATION | Direktor/Vorstandsmitglied | - |
FORMOSA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 09.07.2021 |
CECI Engineering Consultants, Inc. | Direktor/Vorstandsmitglied | - |
Soochow University /Taiwan/ | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Yue Hui Su
Unternehmen | Position | Ende |
---|---|---|
TWI PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | - |
Soochow University | Corporate Officer/Principal | - |
BANK OF KAOHSIUNG CO., LTD. | Direktor/Vorstandsmitglied | - |
Ausbildung von Yue Hui Su
National Taiwan University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
MAKALOT INDUSTRIAL CO., LTD. | Consumer Non-Durables |
BANK OF KAOHSIUNG CO., LTD. | Finance |
IN WIN DEVELOPMENT INC. | Electronic Technology |
ENNOCONN CORPORATION | Electronic Technology |
FORMOSA PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
CECI Engineering Consultants, Inc. | |
TWi Pharmaceuticals, Inc.
TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |